LCN2 and cirrhosis of liver: Among the novel serum or urine biomarkers to predict acute kidney injury (AKI) after liver transplantation in patients with liver cirrhosis, neutrophil gelatinase-associated lipocalin (NGAL) along with cystatin C has been studied in the largest volume of studies1.